Register Now: IKRIS Breast Cancer Awareness Run 2022

Tag Archives: Generic version of Revlimid

Cipla Gets the Final Approval for Generic Version of Revlimid by US FDA

On September 7’th, 2022, Cipla Ltd announced that it has received final approval for its generic version (ANDA) of Lenalidomide […]

September 12, 2022